Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Joan Puñet-Ortiz
Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Institute of Virology, University Medical Center, Albert-Ludwigs-University Freiburg, Freiburg, Germany; Faculty of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany
Martin Messerle
Institute of Virology, Hannover Medical School, Hannover, Germany
Annette Oxenius
Institute of Microbiology, Department of Biology, ETH Zürich, Zürich, Switzerland
Stipan Jonjic
Center for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia; Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Astrid Krmpotić
Department of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Immunology Unit, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
Viral infections are controlled, and very often cleared, by activated T lymphocytes. The inducible co-stimulator (ICOS) mediates its functions by binding to its ligand ICOSL, enhancing T-cell activation and optimal germinal center (GC) formation. Here, we show that ICOSL is heavily downmodulated during infection of antigen-presenting cells by different herpesviruses. We found that, in murine cytomegalovirus (MCMV), the immunoevasin m138/fcr-1 physically interacts with ICOSL, impeding its maturation and promoting its lysosomal degradation. This viral protein counteracts T-cell responses, in an ICOS-dependent manner, and limits virus control during the acute MCMV infection. Additionally, we report that blockade of ICOSL in MCMV-infected mice critically regulates the production of MCMV-specific antibodies due to a reduction of T follicular helper and GC B cells. Altogether, these findings reveal a novel mechanism evolved by MCMV to counteract adaptive immune surveillance, and demonstrates a role of the ICOS:ICOSL axis in the host defense against herpesviruses.